Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Carmen Montoto

ResearcherPublications, citations & collaboration network

Carmen Montoto is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 29 works, 243 citations, an h-index of 10 and an i10-index of 10.

29
Works
243
Citations
10
h-index
10
i10-index

How has Carmen Montoto's publication output changed over time?

ScholarIQpublication output · 2005–2024

Output grew0% over the shown period — from 1 works in 2005 to 1 in 2024.

1
1
2
4
1
1
1
2005201920202021202220232024

What are the most-cited papers on Carmen Montoto?

ScholarIQmost cited works
Prevalence and characterization of breakthrough pain in patients with cancer in Spain: the CARPE-DIO study
Concepción Pérez, Ana Blasco, Á. F. Gândara, A Mañas, M. J. Rodríguez-López, Vicente Martínez, Alonso Fernández-Nistal, Carmen Montoto
Scientific Reports. 201937 CitationsOPEN ACCESS
Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey
Pilar Román-Sánchez, Pedro Conthe, Javier García-Alegría, J. Forteza-Rey, M. Montero, Carmen Montoto, for the Heart Failure Working Group of the Spanish Society of Internal Medicine
S139075330. 200532 CitationsOPEN ACCESS
Clinical characteristics and prognostic factors for Crohn’s disease relapses using natural language processing and machine learning: a pilot study
Fernando Gomollón, Javier P. Gisbert, Iván Guerra, Rocío Plaza, Ramón Pajares Villarroya, Luis Moreno Almazán, Ma Carmen López Martín, Mercedes Domínguez Antonaya, María Isabel Vera Mendoza, Jesús Aparicio, Vicente Martı́nez, Ignacio Tagarro, Alonso Fernández-Nistal, Sara Lumbreras, Claudia Maté, Carmen Montoto
European Journal of Gastroenterology & Hepatology. 202132 CitationsOPEN ACCESS
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an <i>in silico</i> systems biology-based approach
Enric Carcereny, Alonso Fernández-Nistal, Araceli López, Carmen Montoto, Andrea Naves, Cristina Segú-Vergés, Mireia Coma, Guillem Jorba, Baldomero Oliva, José Manuel Mas
Oncotarget. 202124 CitationsOPEN ACCESS
Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate
José Ramón Gutiérrez-Casares, Javier Quintero, Guillem Jorba, Valentin Junet, Vicente Martínez, Tamara Pozo-Rubio, Baldomero Oliva, Xavier Daura, José Manuel Mas, Carmen Montoto
Frontiers in Psychiatry. 202123 CitationsOPEN ACCESS

Related on ScholarIQ

Prevalence and characterization of breakthrough pain in patients with cancer in Spain: the CARPE-DIO study
Paper
Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey
Paper
Clinical characteristics and prognostic factors for Crohn’s disease relapses using natural language processing and machine learning: a pilot study
Paper
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an <i>in silico</i> systems biology-based approach
Paper
Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate
Paper
Evaluation of Natural Language Processing for the Identification of Crohn Disease–Related Variables in Spanish Electronic Health Records: A Validation Study for the PREMONITION-CD Project
Paper
470M+ articles · free account